StockStory.org on MSN
Vertex Pharmaceuticals (NASDAQ:VRTX) beats Q1 CY2026 sales expectations
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) in Q1 CY2026, with sales up 7.8% year on year to $2.99 billion. The ...
Anthropic's tieup with Freshfields and the emergence of vibe-coding as market-ready tools underline GenAI's growing presence ...
Google retired Vertex AI and launched Gemini Enterprise Agent Platform at Cloud Next 2026. Here is how the Build, Scale, ...
Google has replaced its Vertex AI platform with the new Gemini Enterprise Agent Platform, marking a shift from model-centric tools to a full-stack system for building, scaling, and governing AI agents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results